PX1 Research provides reference-grade GHRP-2 Acetate for institutional and academic research applications. Every batch undergoes rigorous RP-HPLC and ESI-MS analysis to verify peptide sequence identity, purity exceeding 99%, and strict endotoxin compliance. Designed strictly for in vitro assays and preclinical secretagogue pharmacology models, our USA-manufactured GHRP-2 Acetate ensures reproducible quantitative data across all research workflows.
PX1 Research provides reference-grade GHRP-2 Acetate for institutional and academic research applications. Every batch undergoes rigorous RP-HPLC and ESI-MS analysis to verify peptide sequence identity, purity exceeding 99%, and strict endotoxin compliance. Designed strictly for in vitro assays and preclinical secretagogue pharmacology models, our USA-manufactured GHRP-2 Acetate ensures reproducible quantitative data across all research workflows.
When procurement officers and principal investigators search for GHRP-2 Acetate for sale, obtaining research-grade material with verified analytical purity is paramount to experimental integrity. GHRP-2 (Growth Hormone Releasing Peptide-2, also known as pralmorelin) is a synthetic hexapeptide classified as a potent growth hormone secretagogue (GHS). It acts as a selective agonist at the growth hormone secretagogue receptor 1a (GHSR-1a). In laboratory settings, GHRP-2 Acetate serves as a crucial reference compound for evaluating pituitary somatotrope signaling pathways, ghrelin receptor kinetics, and neuroendocrine axis modulation.
To obtain consistent, publication-quality results in cell culture or animal models, researchers require GHRP-2 Acetate formulated under strict quality control standards. Impurities such as truncated peptide sequences, residual TFA salts, or endotoxin contamination can confound baseline measurements, alter receptor affinity studies, or induce non-specific inflammatory responses in vitro. PX1 Research addresses these strict experimental requirements by delivering high-purity research peptides backed by comprehensive, lot-specific documentation.
GHRP-2 is a synthetic hexapeptide with the primary amino acid sequence D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2. As an acetate salt, its molecular formula is optimized for chemical stability and aqueous solubility, facilitating accurate reconstitution in sterile assay buffers. The peptide exhibits high binding affinity for the GHSR-1a receptor, a G-protein coupled receptor (GPCR) predominantly expressed in the anterior pituitary gland and hypothalamus.
Pharmacological characterization in cell-free and cell-based assays indicates that GHRP-2 activation of GHSR-1a initiates an intracellular signaling cascade mediated by phospholipase C (PLC). This activation drives the generation of inositol trisphosphate (IP3) and diacylglycerol (DAG), causing a transient influx of intracellular calcium ions (Ca2+). This calcium signaling mechanism directly stimulates the exocytosis of growth hormone (GH) storage vesicles in pituitary somatotropes. Unlike endogenous growth hormone-releasing hormone (GHRH), which operates primarily through the adenylate cyclase/cAMP pathway, GHRP-2 utilizes distinct GPCR pathways, making it a valuable tool in dual-receptor secretagogue research.
In preclinical research models, GHRP-2 Acetate is extensively utilized to map neuroendocrine secretagogue activity. Rodent and non-human primate studies have demonstrated that GHRP-2 administration induces a dose-dependent surge in systemic growth hormone concentrations. Because GHRP-2 acts synergistically with endogenous or exogenous GHRH, researchers frequently utilize it in co-administration paradigms to investigate ceiling effects in somatotropin release.
Beyond its direct pituitary actions, GHRP-2 exhibits cross-reactivity with ghrelin signaling networks involved in metabolic regulation and appetite stimulation. In vitro studies using hypothalamic neuronal cultures show that GHRP-2 binding to GHSR-1a activates neuropeptide Y (NPY) and agouti-related protein (AgRP) neurons. This cross-receptor activation provides researchers with a robust model for dissecting central energy homeostasis, orexigenic pathways, and gut-brain signaling dynamics without requiring native, highly unstable acylated ghrelin peptides. Researchers interested in broader neuroendocrine frameworks can browse our comprehensive catalog of all peptides for complementary research tools.
In secretagogue receptor pharmacology, selecting the appropriate peptide candidate depends heavily on the desired receptor selectivity, potency, and secondary pathway activation. GHRP-2, GHRP-6, and Ipamorelin represent three distinct generations of growth hormone secretagogues, each exhibiting unique operational profiles in preclinical models.
When comparing these agents, GHRP-2 Acetate demonstrates significantly higher potency in activating GHSR-1a driven GH release compared to GHRP-6 Acetate, while producing a lower orexigenic (appetite-stimulating) response. Conversely, Ipamorelin is characterized by exceptional selectivity; unlike GHRP-2 and GHRP-6, Ipamorelin does not stimulate baseline cortisol or prolactin release even at elevated concentration thresholds. Researchers evaluating non-GHSR-1a pathways alongside GHRH receptor agonists often pair these hexapeptides with modified GHRH analogs such as CJC-1295 No DAC to examine synergistic somatotrope stimulation in isolated tissue assays. Detailed mechanistical analyses of these interactions are archived in our research library hub.
Proper reconstitution technique is essential to preserve the structural integrity of GHRP-2 Acetate and prevent peptide aggregation or surface adsorption. Lyophilized GHRP-2 Acetate should be brought to room temperature prior to opening the container to minimize moisture condensation inside the vial.
For sterile laboratory workflows, reconstitute the lyophilized powder using premium grade bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Gentle rotational swirling is recommended to achieve complete dissolution; severe mechanical agitation, such as vigorous shaking or high-speed vortexing, should be avoided as it can induce shear stress and cause peptide denaturation or aggregation. Once reconstituted, stock solutions should be aliquoted into single-use polypropylene microcentrifuge tubes to prevent repeated freeze-thaw cycles, which degrade peptide potency over time.
Assaying data validity begins with verifiable chemical purity. PX1 Research subjects every batch of GHRP-2 Acetate to exhaustive analytical validation before release. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is utilized to determine overall peptide purity, ensuring that target compound concentrations exceed 99% with minimal single-impurity profiles.
Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular weight and amino acid sequence identity, guaranteeing the absence of misfolded isomers or incomplete peptide fragments. Additionally, because bacterial endotoxins (lipopolysaccharides) alter cell viability and introduce systemic inflammatory artifacts in preclinical assays, PX1 Research conducts LAL (Limulus Amebocyte Lysate) endotoxin testing on all lots, enforcing strict limits below 0.01 EU/mg. Every shipment includes access to our lot-specific Certificates of Analysis (COA), allowing investigators to audit raw chromatographic and spectral data prior to initiating experiments.
To preserve peptide stability and prevent hydrolytic degradation, lyophilized GHRP-2 Acetate must be stored under controlled thermal conditions. For short-term storage (under 30 days), desiccated lyophilized vials may be kept at 2°C to 8°C. For long-term preservation (up to 24 months), vials should be stored at -20°C or -80°C in a frost-free freezer, protected from light exposure.
Reconstituted liquid solutions of GHRP-2 Acetate in bacteriostatic water remain stable at 2°C to 8°C for up to 28 days. If reconstituted in non-preserved sterile saline or PBS, solutions must be used immediately or within 24 hours under chilled conditions. Maintaining these environmental parameters ensures optimal binding affinity and reproducibility across longitudinal laboratory experiments.
PX1 Research is dedicated to supporting academic, biotechnology, and institutional laboratories across the United States with reference-standard research compounds. All peptides offered by PX1 are synthesized in state-of-the-art, GMP-compliant facilities within the USA and verified by independent ISO 17025 accredited analytical laboratories.
We maintain transparent supply chains, complete lot traceability, and strict adherence to analytical standards. For high-throughput screening projects, university research contracts, or large-scale preclinical trials, laboratories can access streamlined procurement through our wholesale lab account portal. All orders are packaged in temperature-controlled, secure containment and dispatched via same-day shipping from our distribution centers in California and Arizona.
What is the purity level of PX1 Research GHRP-2 Acetate?
Every lot of GHRP-2 Acetate supplied by PX1 Research is verified via RP-HPLC to meet or exceed 99% chemical purity. Detailed analytical results, including mass spectrometry identity verification, are published on our lot-specific COAs.
What primary receptor does GHRP-2 Acetate target in research models?
GHRP-2 Acetate functions as a selective agonist at the growth hormone secretagogue receptor 1a (GHSR-1a), stimulating downstream intracellular calcium signaling in pituitary somatotrope cellular models.
How should lyophilized GHRP-2 Acetate be stored upon receipt?
Lyophilized GHRP-2 Acetate should be stored at -20°C in a dry, dark environment upon arrival. Sealed vials kept at -20°C remain stable for up to 24 months.
What solvent is recommended for reconstituting GHRP-2 Acetate for laboratory use?
GHRP-2 Acetate reconstitutes readily in sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Swirl gently to dissolve; do not vortex.
Does PX1 Research perform endotoxin testing on GHRP-2 Acetate?
Yes. All batches undergo LAL testing to verify endotoxin levels remain strictly below 0.01 EU/mg, ensuring suitability for sensitive cell culture and in vivo animal research models.
What is the key functional difference between GHRP-2 and Ipamorelin in secretagogue research?
While both target GHSR-1a, GHRP-2 exhibits higher overall secretagogue potency but may induce mild baseline ACTH/cortisol activity in preclinical models, whereas Ipamorelin displays near-absolute receptor selectivity without altering secondary neuroendocrine hormones.
Where is PX1 Research GHRP-2 Acetate manufactured and shipped from?
PX1 Research compounds are manufactured in domestic GMP-compliant facilities in the USA. Orders ship same-day (Monday through Friday) from our CA and AZ logistics hubs.
Is GHRP-2 Acetate approved for human clinical use or administration?
No. GHRP-2 Acetate supplied by PX1 Research is sold strictly for in vitro laboratory research and preclinical experimental use. It is not intended for human consumption, clinical diagnostic, or therapeutic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.